Latest Safety News

Melbana Energy Limited’s March quarter report details modest crude production from the Alameda-2 well in Cuba and ongoing preparations for the Amistad-11 drilling, which remains on hold due to a joint partner’s funding default. The company holds $2 million in cash and continues to process seismic data to refine its subsurface models.

TMK Energy Limited (ASX: TMK) reported a 48% increase in average daily gas production at its Gurvantes XXXV Coal Seam Gas Project in March 2026, achieving a new peak daily rate before temporarily curtailing output for operational safety. The company also secured a Memorandum of Understanding with Mongolia’s regulator to facilitate power generation and progress towards an exploitation license.

Macarthur Minerals Limited (ASX:MIO) has obtained Program of Work approval from the Western Australian Department of Mines, enabling bulk sampling and infrastructure development at its Lake Giles Iron Project. This milestone supports the company’s strategic progression toward potential production.

Select Harvests Limited has announced the resignation of CEO and Managing Director David Surveyor, who led the company through a significant operational transformation and financial recovery from a loss in FY23 to a $31.8 million profit in FY25. Surveyor will remain for a six-month transition period while the company searches for his successor.

Orora has lowered its FY26 EBIT forecast for its Saverglass business due to direct operational impacts and indirect market shifts stemming from the ongoing Middle East conflict, while maintaining stable guidance for other segments.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Radiopharm Theranostics has received a positive recommendation to escalate the dose of its 177Lu-RAD202 radiotherapeutic in a Phase 1 trial targeting HER2-positive advanced solid tumors, maintaining its timeline to complete dose escalation by year-end 2026.

Perenti Limited has secured a 12-month extension of its underground mining services contract with Regis Resources at the Duketon Operations, increasing contract value by approximately A$180 million and extending the term to at least March 2029 without additional capital requirements.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.

Etherstack’s Australian subsidiary Auria Wireless has landed a multi-year contract with the Department of Home Affairs, valued at around A$9 million initially and potentially rising to A$15 million with extensions.

Fiducian Group Limited has responded to a sharp share price drop by denying any undisclosed information and downplaying the impact of new APRA licence conditions on its operations.

Emyria Limited has launched a targeted recruitment campaign in New South Wales to establish its fourth state-based clinical operation, aiming to tap into Australia's largest mental health market amid rising psychological injury claims.